Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
S. Mühlebach, M. J. Moor, P. A. Wyss & M. H. Bickel. (1991) Kinetics of distribution and elimination of DDE in rats. Xenobiotica 21:1, pages 111-120.
Read now
Read now
M. H. Bickel. (1989) What Can the Use of Unmetabolizable Lipophilic Compounds Tell About the Importance of Drug Metabolism?. Drug Metabolism Reviews 20:2-4, pages 441-447.
Read now
Read now
Lori A. Gallenberg & Mary JO Vodicnik. (1989) Transfer of Persistent Chemicals in Milk. Drug Metabolism Reviews 21:2, pages 277-317.
Read now
Read now
Robert L. Binder, Mark J. Melancon & John J. Lech. (1984) Factors Influencing the Persistence and Metabolism of Chemicals in Fish. Drug Metabolism Reviews 15:4, pages 697-724.
Read now
Read now
Z. H. Israili & P. G. Dayton. (1984) Enhancement of Xenobiotic Elimination: Role of Intestinal Excretion. Drug Metabolism Reviews 15:5-6, pages 1123-1159.
Read now
Read now
Silvio Garattini. (1982) TCDD Toxicology with Particular Reference to Seveso: Introductory Remarks. Drug Metabolism Reviews 13:3, pages 345-353.
Read now
Read now
W. Robert Jondorf. (1981) Drug-metabolizing Enzymes as Evolutionary Probes. Drug Metabolism Reviews 12:2, pages 379-430.
Read now
Read now
S. Mühlebach & M. H. Bickel. (1981) Pharmacokinetics in rats of 2,4,5,2′,4′,5-hexachlorobiphenyl, an unmetabolizable lipophilic model compound. Xenobiotica 11:4, pages 249-257.
Read now
Read now
Articles from other publishers (22)
Kenneth L. Kirk. 2009. PATAI'S Chemistry of Functional Groups. PATAI'S Chemistry of Functional Groups.
S.F. Mühlebach, G. Karlaganis & U.E. Honegger. (2006) Kinetic assessment of persistent halogenated xenobiotics in cell culture models. Comparison of mono- and poly-halogenated compounds. Chemosphere 62:11, pages 1838-1845.
Crossref
Crossref
Larry L NeedhamRichard Y Wang. (2002) Analytic considerations for measuring environmental chemicals in breast milk.. Environmental Health Perspectives 110:6.
Crossref
Crossref
Allan Astrup Jensen. 1996. Drugs and Human Lactation. Drugs and Human Lactation
679
706
.
G. Gordon Gibson. 1992. Principles and Practice of Environmental Medicine. Principles and Practice of Environmental Medicine
139
158
.
Usha Varanasi, John E. Stein, Lyndal L. Johnson, Tracy K. Collier, Edmundo Casillas & Mark S. Myers. 1992. Ecological Indicators. Ecological Indicators
461
498
.
S. Mühlebach, P. A. Wyss & M. H. Bickel. (2009) The Use of 2,4,5,2′,4′,5′‐Hexachlorobiphenyl (6‐CB) as an Unmetabolizable Lipophilic Model Compound. Pharmacology & Toxicology 69:6, pages 410-415.
Crossref
Crossref
Steven I. Shedlofsky, Niel C. Hoglen, Larry E. Rodman, Ron Honchel, Farrel R. Robinson, Alice T. Swim, Craig J. McClain & Larry W. Robertson. (1991) 3,3′,4,4′-Tetrabromobiphenyl sensitizes rats to the hepatotoxic effects of endotoxin by a mechanism that involves more than tumor necrosis factor. Hepatology 14:6, pages 1201-1208.
Crossref
Crossref
Kenneth L. KirkKenneth L. Kirk. 1991. Biochemistry of the Elemental Halogens and Inorganic Halides. Biochemistry of the Elemental Halogens and Inorganic Halides
239
285
.
Kenneth L. KirkKenneth L. Kirk. 1991. Biochemistry of the Elemental Halogens and Inorganic Halides. Biochemistry of the Elemental Halogens and Inorganic Halides
191
238
.
Barbara J. Ring, Karen R. Seitz, Lori A. Gallenberg & Mary Jo Vodicnik. (1990) The effect of diet and litter size on the elimination of 2,4,5,2?,4?,5?-[14C]hexachlorobiphenyl from lactating mice. Toxicology and Applied Pharmacology 104:1, pages 9-16.
Crossref
Crossref
ALLAN ASTRUP JENSEN. 1989. Halogenated Biphenyls, Terphenyls, Naphthalenes, Dibenzodioxins and Related Products. Halogenated Biphenyls, Terphenyls, Naphthalenes, Dibenzodioxins and Related Products
345
380
.
Diogo Pupo Nogueira, José Maria Pacheco de Souza, Sérgio Colacioppo, Jorge da Rocha Gomes, Joselito Bomfim Brandão & Marlene Lopes Assis de Souza. (1987) Acúmulo de policloretos de bifenila na população do Grande São Paulo, Brasil. Revista de Saúde Pública 21:4, pages 279-290.
Crossref
Crossref
Allan Astrup Jensen. (1987) Polychlorobiphenyls (PCBs), polychlorodibenzo-p-dioxins (PCDDs) and polychlorodibenzofurans (PCDFs) in human milk, blood and adipose tissue. Science of The Total Environment 64:3, pages 259-293.
Crossref
Crossref
D. V. Parke. 1987. The Future of Predictive Safety Evaluation. The Future of Predictive Safety Evaluation
3
38
.
P.N. Shaw & J.B. Houston. (1986) Temporal effects on antipyrine metabolite kinetics in aroclor 1254-treated rats. Toxicology and Applied Pharmacology 84:2, pages 232-240.
Crossref
Crossref
L S Birnbaum. (1985) The role of structure in the disposition of halogenated aromatic xenobiotics.. Environmental Health Perspectives 61, pages 11-20.
Crossref
Crossref
W. R. Jondorf. (1983) Unmetabolisable polyhalogenated compounds: Implications for mammalian and other vertebrate species. Veterinary Research Communications 7:1, pages 277-283.
Crossref
Crossref
A.G. Renwick. 1983. Biological Basis of Detoxication. Biological Basis of Detoxication
151
179
.
T. A. Gasiewicz, J. R. Olson, L. H. Geiger & R. A. Neal. 1983. Human and Environmental Risks of Chlorinated Dioxins and Related Compounds. Human and Environmental Risks of Chlorinated Dioxins and Related Compounds
495
525
.
M. H. Bickel. (1982) Polychlorinated persistent compounds. Experientia 38:8, pages 879-882.
Crossref
Crossref
. (2012) COMMUNICATIONS. British Journal of Pharmacology 75:S1.
Crossref
Crossref